Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially starve tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients.
View Top Employees from Calithera BiosciencesWebsite | http://www.calithera.com |
Ticker | CALA |
Revenue | $22 million |
Funding | $126 million |
Employees | 49 (49 on RocketReach) |
Founded | 2010 |
Address | 343 Oyster Point Blvd. Suite 200, South San Francisco, California 94080, US |
Phone | (650) 870-1000 |
Technologies |
JavaScript,
HTML,
PHP
+44 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
Web Rank | 4 Million |
Keywords | Calithera Biosciences, Cb-839, Calithera Ir, Arginase License Agreement, With Mars, Inc, Calithera |
Competitors | CrystalGenomics, Inc., GlycoMimetics, Mimetogen Pharmaceuticals Inc., Onconova Therapeutics, Vidac Pharma |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies |
Looking for a particular Calithera Biosciences employee's phone or email?
The Calithera Biosciences annual revenue was $22 million in 2024.
Matt Gross is the Vice President Of Business Development of Calithera Biosciences.
49 people are employed at Calithera Biosciences.
Calithera Biosciences is based in South San Francisco, California.
The NAICS codes for Calithera Biosciences are [541, 3254, 32541, 325, 32, 54].
The SIC codes for Calithera Biosciences are [28, 283].